You are here

allergies

Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?

Fierce Biotech

Fri, 02/9/24 - 11:20 am

Alladapt's 15-allergen drug desensitizes kids to multiple foods, teeing up pivotal program

Fierce Biotech

Tue, 06/13/23 - 10:50 am

Alladapt Immunotherapeutics

clinical trials

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases

Yahoo/Businesswire

Thu, 06/8/23 - 10:00 am

Revolo drops dab of midphase data on would-be Dupixent rival

Fierce Biotech

Wed, 04/19/23 - 10:11 am

Revolo Biotherapeutics

clinical trials

Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab

Fierce Biotech

Wed, 08/24/22 - 10:40 pm

Third Harmonic Bio

inflammatory diseases

Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases

BioSpace

Thu, 06/2/22 - 10:35 am

Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease

Fierce Biotech

Sun, 11/14/21 - 10:52 pm

multiple sclerosis

Allergy specialist Stallergenes taps Aptar for digital delivery

Pharmaforum

Wed, 10/27/21 - 10:55 am

Stallergenes Greer

allergen immunotherapy

Watch out Claritin: Aldeyra announces clean sweep in PhIII for new allergy drug

Endpoints

Tue, 04/27/21 - 11:21 pm

Aldeyra Therapeutics

clinical trials

ragweed pollen allergy

Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair

BioSpace

Tue, 04/13/21 - 10:03 pm

RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193

Pharmaceutical Business Review

Thu, 10/24/19 - 10:13 am

RAPT Therapeutics

atopic dermatitis

clinical trials

130 medicines in development for asthma, allergies and other respiratory diseases

PhRMA

Thu, 02/21/19 - 11:02 pm

respiratory disease

drug development

Strange bedfellows: Allergy paid search pits diverse brands against each other

Fierce Pharma

Sun, 09/16/18 - 02:27 pm

Anthem Taps Artificial Intelligence Space With Allergy Research Trial

Forbes

Wed, 08/1/18 - 10:33 am

clinical trials

artificial intelligence

Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains

CP Wire

Mon, 07/2/18 - 10:18 am

allergic testing

A final flop signals the bitter end to Circassia’s big plans for allergy R&D

Endpoints

Tue, 04/18/17 - 09:34 am

Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.

Yahoo

Tue, 03/21/17 - 06:59 pm

Drug for Dust Mite Allergy Approved by FDA

Xtalks

Fri, 03/3/17 - 10:27 pm

Merck Calls Time On U.S. Allergy Market

Seeking Alpha

Thu, 07/28/16 - 09:04 am

Regeneron says its allergy drug could be as big as PCSK9 blockers

Fierce Pharma

Wed, 02/11/15 - 05:40 pm

Pages